Kore Private Wealth’s Applied Therapeutics APLT Stock Holding History

Kore Private Wealth’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-125,000	Closed	-$119K	–	267
2022 Q2	$119K	Hold	125,000	–	–	0.02%	288
2022 Q1	$264K	Hold	125,000	–	–	0.03%	269
2021 Q4	$1.12M	Buy	+125,000	New	+$1.64M	0.14%	114
2020 Q4	–	Sell	-125,000	Closed	-$2.6M	–	337
2020 Q3	$2.6M	Hold	125,000	–	–	0.5%	44
2020 Q2	$4.52M	Buy	+125,000	New	+$5.23M	0.92%	24

Other funds holding APLT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Kore Private Wealth's APLT Position: Q3 2022 in Review

Kore Private Wealth sold out of Applied Therapeutics (APLT) in Q3 2022, closing a stake of 125,000 shares — an estimated $119K sold.

Kore Private Wealth first reported a position in APLT in Q2 2020 and held it in 5 quarters. The position peaked at $4.52M in Q2 2020. 44 funds tracked by Wall St. Rank hold APLT as of Q3 2022.

Kore Private Wealth reported no remaining Applied Therapeutics position as of Q3 2022 after selling out during the quarter.
Kore Private Wealth sold 125,000 Applied Therapeutics shares in Q3 2022, an estimated $119K.
Kore Private Wealth first reported a position in Applied Therapeutics in Q2 2020 and held it in 5 quarters.
Kore Private Wealth's Applied Therapeutics position peaked at $4.52M in Q2 2020.
44 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.